tobitimelogo
      
  Novartis Pharma US
spacer
      
transpx
 
 

:: Who gets Pseudomonas aeruginosa (Pa) infections? ::
 
Repeated Pseudomonas aeruginosa infections are common in people with   cystic fibrosis.
 

Most people with cystic fibrosis are likely to develop Pseudomonas aeruginosa     infections by the time they are teenagers.

Between the ages of 6 and 10, about 40% of patients with cystic fibrosis have Pseudomonas aeruginosa infections
By the age of 17, nearly 60% of people with cystic fibrosis have Pseudomonas aeruginosa infections in their lungs
Up to 80% of adults with cystic fibrosis between the ages of 25 and 34 have Pseudomonas aeruginosa infections
   
Fortunately, there are treatment options like TOBI® (Tobramycin Inhalation Solution, USP)    
to help manage Pseudomonas aeruginosa infections in people with cystic fibrosis.
 

Are there symptoms of Pseudomonas aeruginosa infections?
   
   
  
 
tobi isi
nova-images
TBI-900571-A
footer separator
Use of Web site is governed by the Terms of Use and Privacy Statement .
Copyright © 2010 Novartis Pharmaceuticals Corporation. All rights reserved.
Novartis proudly supports the Patient Assistance Now program.